Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Imaginostics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Imaginostics

Imaginostics

Pre-Seed

Imaginostics: A health tech startup innovating MRI technology, based in Boston and Baltimore.

HQ
Cambridge, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Imaginostics is a health tech startup focused on revolutionizing diagnostic imaging through advanced magnetic resonance imaging (MRI) technology. Based in Boston and Baltimore, the company aims to enhance the accuracy and efficiency of medical diagnostics. Their flagship product, QUTE-CE MRI, offers innovative solutions for healthcare providers, particularly in the fields of oncology and other critical medical areas.

Imaginostics has made significant strides in the health tech industry, highlighted by their participation in the Hello Tomorrow Global Summit and collaboration with the Paris Saclay Cancer Cluster. These achievements underscore their commitment to advancing medical imaging technology and improving patient outcomes. Their work has garnered attention and support from notable entities within the healthcare and technology sectors.

Imaginostics - Similar Companies

Alpha-Mri logo

Alpha-Mri

HeartVista logo

HeartVista

Neuro42 logo

Neuro42

Imaginab logo

Imaginab

imaginab.com

Emagine Solutions Technology logo

Emagine Solutions Technology

SpinTech logo

SpinTech

Elucid Bioimaging logo

Elucid Bioimaging

Smart Scan Medical Imaging logo

Smart Scan Medical Imaging

myssmi.com

Imago Systems logo

Imago Systems

imagosystems.com

Turing Medical logo

Turing Medical

turingmedical.com

Cerehealth logo

Cerehealth

Resilience Imaging logo

Resilience Imaging

Real Time Imaging Technologies logo

Real Time Imaging Technologies

Lumedica logo

Lumedica

Magnetic Insight logo

Magnetic Insight

Imaginostics - Quick Facts

Who are Imaginostics' competitors?

Companies similar to Imaginostics include Alpha-Mri, HeartVista, Neuro42 and Imaginab.

When was Imaginostics founded?

Imaginostics was founded in 2018.

Where is Imaginostics' headquarters located?

Imaginostics' headquarters is located in Cambridge, MA, US.

When was Imaginostics' last funding round?

Imaginostics' most recent funding round was for $915.9k (USD) in September 2022.

How much has Imaginostics raised to-date?

As of Sep 15, 2022, Imaginostics has raised a total of $3.1M (USD).

How many employees does Imaginostics have?

Imaginostics has 5 employees as of Feb 4, 2024.

Imaginostics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • MRI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Imaging
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software